PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 56 filers reported holding PRELUDE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,909,256 | $49,091,652 | 0.89% |
| Boxer Capital, LLC | 2,495,018 | $11,228 | 0.52% |
| Baker Brothers Advisors | 10,123,824 | $45,557,208 | 0.26% |
| EcoR1 Capital, LLC | 1,157,452 | $5,208,534 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 72,834 | $328 | 0.03% |
| Woodline Partners LP | 248,000 | $1,116,000 | 0.01% |
| UBS ASSET MANAGEMENT AMERICAS INC | 2,273,894 | $12,961,196 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 36,949 | $166,271 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 116,487 | $524,192 | 0.00% |
| EXCHANGE TRADED CONCEPTS, LLC | 25,428 | $114,426 | 0.00% |
| FMR LLC | 5,940,220 | $26,730,990 | 0.00% |
| STATE OF WISCONSIN INVESTMENT BOARD | 78,300 | $352,350 | 0.00% |
| China Universal Asset Management Co., Ltd. | 687 | $3 | 0.00% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 509,390 | $2,292,255 | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,082,248 | $4,871 | 0.00% |
| TWO SIGMA ADVISERS, LP | 46,800 | $210,600 | 0.00% |
| Renaissance Technologies | 183,300 | $825 | 0.00% |
| Citadel Advisors | 500 | $2,250 | 0.00% |
| Citadel Advisors | 1,200 | $5,400 | 0.00% |
| Citadel Advisors | 36,869 | $165,911 | 0.00% |
External links
This page lists PRELUDE THERAPEUTICS INC's shareholders in Q2 2023. To view PRELUDE THERAPEUTICS INC's shareholder history, click here.